Literature DB >> 12886829

[Autoimmune hemolytic anemia presenting during treatment of chronic hepatitis C with interferon alpha].

Rita Rizzi1, Francesco P Lucarella, Giovanni B Ruggieri, Matteo L'Abbate.   

Abstract

Autoimmune hemolytic anemia has been rarely described in patients with chronic hepatitis C during interferon-alpha therapy. We report a case of Coombs-positive autoimmune hemolytic anemia, occurring 9 months after the onset of monotherapy with interferon-alpha-2b (3 million units thrice in week) for chronic hepatitis C. Interferon withdrawal and prednisone treatment induced a complete remission of hematological findings after 3 months. During a follow-up period of 30 months after cessation of interferon, hemoglobin levels stabilized about 16 g/dL, and the indirect Coombs test turned negative, while the direct Coombs test remained weakly positive; besides, serum alanine aminotransferase values were normal and hepatitis C virus-RNA remained undetectable. In our patient, clinical and laboratory findings suggested a correlation between autoimmune side effects of interferon-alpha and autoimmune hemolytic anemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886829

Source DB:  PubMed          Journal:  Ann Ital Med Int        ISSN: 0393-9340


  1 in total

1.  Hepatocellular carcinoma with chronic B-type hepatitis complicated by autoimmune hemolytic anemia: a case report.

Authors:  Toshie Okada; Keiichi Kubota; Junji Kita; Masato Kato; Tokihiko Sawada
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.